Natural Alternatives International, Inc
Natural Alternatives International, Inc. manufactures private-label nutritional supplements for brands that sell vitamins, minerals, herbs, and other health products to consumers in the U.S. and abroad. It also monetizes its beta-alanine intellectual property through CarnoSyn®, SR CarnoSyn®, and TriBsyn™ raw material sales, licensing, and royalty arrangements.
Tilikausi 2026 · muutos edellisvuodesta
Kehitys 2021–2026
Liiketoiminta
Osuus liikevaihdostaManufacturing of finished nutritional supplement products for third-party brands under customer specifications.
Licensing and royalty income tied to the company's beta-alanine intellectual property and trademarks.
Asiakkaat
The company sells primarily to private-label brands and distributors that market supplements and health products to end consumers. Management says revenue has historically depended on two or three large customers, so order timing, new product launches, and customer marketing plans can materially swing results.
Buy contract manufacturing for vitamins, minerals, herbs, and other nutritional supplements to sell under their own labels.
Outsource production and packaging of consumer health products where formulation quality and supply reliability matter.
Purchase CarnoSyn® or TriBsyn™ raw material for sports nutrition, wellness, healthy aging, and medical foods.
Use the company's patents, trademarks, and trade names in exchange for licensing and royalty payments.
Strategia
Management is focused on diversifying away from a small customer base while improving utilization of its certified facilities. It is also pushing beta-alanine commercialization through raw material sales, new distribution channels, and licensing to broaden revenue sources and reduce dependence on contract manufacturing alone.
Reduces dependence on two or three large buyers and lowers order-timing volatility.
Creates higher-margin IP-linked revenue streams beyond contract manufacturing.
Better utilization and cost control can improve profitability in a low-margin manufacturing model.
Maantiede
Q1/2025The company serves consumers both within and outside the U.S., but the filings provided do not disclose a country revenue split. It operates a wholly owned manufacturing subsidiary in Manno, Switzerland, which gives it a non-U.S. production footprint and exposure to cross-border supply chain, tariff, and foreign exchange effects.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
The biggest company-specific risk is customer concentration, since a few private-label accounts can materially affect sales and quarterly timing. The business is also exposed to tariffs, supply chain disruption, foreign exchange, and geopolitical instability, while the contract manufacturing model remains sensitive to raw material availability, customer demand, and rebate estimates.
- Customer concentrationVaikutus: Korkea
Largest private-label customer represented 31% of total net sales in the six months ended Dec. 31, 2025.
Kohdistuu: A small number of customers drive a large share of revenue and order timing.
- Geopolitical instabilityVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Conflict in Ukraine and the Middle East may disrupt supply chains and energy prices.
Kohdistuu - Tariffs and trade dutiesVaikutus: KeskitasoTodennäköisyys: Matala
The company says tariffs can affect its ability to adjust prices and forecast costs on time.
Kohdistuu: Imported ingredients and cross-border supply chains.
- Foreign exchange volatilityVaikutus: Keskitaso
The Swiss subsidiary creates translation and transaction exposure.
Kohdistuu: Cross-border operations and non-U.S. activity.
Kirjanpito
Harkinnanvaraiset erätManagement estimates future sales to determine rebate accruals, which can materially change net sales.
Vaikutus: Net revenue and gross margin
Large customer orders and shipments can move revenue between quarters.
Vaikutus: Comparability of quarterly results
The Swiss subsidiary is translated into U.S. dollars and can create gains or losses.
Vaikutus: Reported earnings and equity
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Nature's Sunshine Products, Inc
NATR · Pharmaceutical Preparations
Nature’s Sunshine Products is a U.S.-based natural health and wellness company that manufactures and sells nutritional supplements and personal care products.
Niagen Bioscience, Inc.
NAGE · Medicinal Chemicals & Botanical Products
Natural Health Trends Corp
NHTC · Wholesale-Miscellaneous Nondurable Goods
Mannatech, Incorporated
MTEX · Medicinal Chemicals & Botanical Products
Natural Resource Holdings, Inc.
NRHI · Retail-Nonstore Retailers
Goldenwell Biotech, Inc.
GWLL · Food and Kindred Products
Päivitetty: 24.9.2026